Holowesko Partners’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Holowesko Partners’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,322,266	Closed	-$28.9M	–	39
2015 Q3	$28.9M	Buy	1,322,266 +80,000	+6%	+$2.04M	2.01%	23
2015 Q2	$35.4M	Buy	1,242,266 +50,000	+4%	+$1.46M	2.2%	23
2015 Q1	$32.6M	Hold	1,192,266	–	–	2.54%	21
2014 Q4	$31.5M	Hold	1,192,266	–	–	2.76%	17
2014 Q3	$36M	Buy	1,192,266 +22,500	+2%	+$697K	2.82%	19
2014 Q2	$36.8M	Buy	+1,169,766	New	+$37.1M	2.23%	24

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Holowesko Partners's MR Position: Q4 2015 in Review

Holowesko Partners sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2015, closing a stake of 1,322,266 shares — an estimated $28.9M sold.

Holowesko Partners first reported a position in MR in Q2 2014 and held it in 6 quarters. The position peaked at $36.8M in Q2 2014. 119 funds tracked by Wall St. Rank hold MR as of Q4 2015.

Holowesko Partners reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2015 after selling out during the quarter.
Holowesko Partners sold 1,322,266 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2015, an estimated $28.9M.
Holowesko Partners first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2014 and held it in 6 quarters.
Holowesko Partners's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $36.8M in Q2 2014.
119 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2015.

Based on Holowesko Partners's 13F filing for Q4 2015, filed 11 Feb 2016.